Medical Marijuana, Inc. (MJNA)
0.0001
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Medical Marijuana Gross Profit Margin (Quarterly) : 83.04% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 83.04% |
| March 31, 2026 | 79.07% |
| December 31, 2025 | 59.80% |
| September 30, 2025 | 80.60% |
| June 30, 2025 | 78.25% |
| March 31, 2025 | 77.89% |
| December 31, 2024 | 73.28% |
| September 30, 2024 | 78.80% |
| June 30, 2024 | 80.56% |
| March 31, 2024 | 79.80% |
| December 31, 2023 | 27.60% |
| September 30, 2023 | 79.95% |
| June 30, 2023 | 72.17% |
| March 31, 2023 | 76.52% |
| December 31, 2022 | 60.36% |
| September 30, 2022 | 82.11% |
| June 30, 2022 | 76.64% |
| March 31, 2022 | 72.71% |
| December 31, 2021 | 0.00% |
| September 30, 2021 | 72.95% |
| June 30, 2021 | 58.87% |
| March 31, 2021 | 75.71% |
| December 31, 2020 | 83.34% |
| September 30, 2020 | 74.77% |
| June 30, 2020 | 79.66% |
| Date | Value |
|---|---|
| March 31, 2020 | 83.80% |
| December 31, 2019 | 78.12% |
| September 30, 2019 | 75.18% |
| June 30, 2019 | 74.28% |
| March 31, 2019 | 78.22% |
| December 31, 2018 | 70.09% |
| September 30, 2018 | 71.65% |
| June 30, 2018 | 60.55% |
| March 31, 2018 | 68.84% |
| December 31, 2017 | 70.95% |
| September 30, 2017 | 62.78% |
| June 30, 2017 | 69.23% |
| March 31, 2017 | 66.26% |
| December 31, 2016 | 48.43% |
| September 30, 2016 | 50.62% |
| June 30, 2016 | 58.00% |
| March 31, 2016 | 47.37% |
| December 31, 2015 | 40.62% |
| September 30, 2015 | 11.33% |
| June 30, 2015 | 32.61% |
| March 31, 2015 | 41.13% |
| December 31, 2014 | 25.38% |
| September 30, 2014 | 54.39% |
| June 30, 2014 | 36.65% |
| March 31, 2014 | 52.30% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ZeroStack Corp. | -7.63% |
| Interpace Biosciences, Inc. | 61.91% |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | -- |
| Stella Diagnostics, Inc. | -14.09% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.18% |
| Return on Assets | -1.63% |
| Return on Invested Capital | -2.07% |
| Profit Margin (Quarterly) | -0.89% |
| Operating Margin (Quarterly) | -8.63% |
| Return on Net Operating Assets | -1.95% |